10
Participants
Start Date
February 29, 2016
Primary Completion Date
July 19, 2019
Study Completion Date
July 19, 2019
Harvoni
12 weeks for naïve subjects or non-cirrhotic treatment experienced subjects; or 24 weeks for treatment experienced subjects with cirrhosis
Epclusa
once daily for 12 weeks (naïve subjects, non-cirrhotic treatment experienced or treatment experienced subjects with compensated cirrhosis) for genotype 1-6 subjects.
Icahn School of Medicine at Mount Sinai, New York
Collaborators (1)
Gilead Sciences
INDUSTRY
Icahn School of Medicine at Mount Sinai
OTHER